Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?

BACKGROUND Amphetamine, methamphetamine, and cocaine are suspected of being pulmonary hypertension risk factors based on a small number of case reports along with pharmacologic similarities to fenfluramine, a diet drug associated with pulmonary arterial hypertension (PAH). We sought to determine whether rates of stimulant use are increased in patients believed to have idiopathic PAH compared with patients with PAH and known risk factors and patients with chronic thromboembolic pulmonary hypertension (CTEPH). METHODS In this retrospective study, rates of stimulant use were determined for 340 patients with idiopathic PAH, PAH and known risk factors, or CTEPH seen between November 2002 and April 2004. "Stimulant" use was defined as any reported use of amphetamine, methamphetamine, or cocaine. Odds of stimulant use were calculated using a polychotomous logistic regression model. RESULTS A history of stimulant use was found in 28.9% of patients with a diagnosis of idiopathic PAH, compared with 3.8% of patients with PAH and a known risk factor, and 4.3% of patients with CTEPH. After adjustment for differences in age, patients with idiopathic PAH were 10.14 times (95% confidence interval, 3.39 to 30.3; p < 0.0001) more likely to have used stimulants than patients with PAH and known risk factors, and 7.63 times (95% confidence interval, 2.99 to 19.5; p < 0.0001) more likely to have used stimulants than patients with CTEPH. CONCLUSIONS Patients with idiopathic PAH are significantly more likely to have used stimulants than patients with other forms of pulmonary hypertension.

[1]  R. Speich,et al.  Clinical classification of pulmonary hypertension. , 2004, Journal of the American College of Cardiology.

[2]  M. Humbert,et al.  Serotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension , 2004, Circulation research.

[3]  A. Harmar,et al.  Overexpression of the 5-Hydroxytryptamine Transporter Gene: Effect on Pulmonary Hemodynamics and Hypoxia-Induced Pulmonary Hypertension , 2004, Circulation.

[4]  W. Schlenger,et al.  Injection Drug Use Among Stimulant Users in a National Sample , 2004, The American journal of drug and alcohol abuse.

[5]  M. Olfson,et al.  National trends in the treatment of attention deficit hyperactivity disorder. , 2003, The American journal of psychiatry.

[6]  M. Humbert,et al.  Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension. , 2003, American journal of respiratory and critical care medicine.

[7]  J. Faber,et al.  Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo. , 2002, American journal of physiology. Heart and circulatory physiology.

[8]  R. Rothman,et al.  Therapeutic and adverse actions of serotonin transporter substrates. , 2002, Pharmacology & therapeutics.

[9]  M. Humbert,et al.  Risk factors for pulmonary arterial hypertension. , 2001, Clinics in chest medicine.

[10]  A. Kokesova,et al.  Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels. , 2001, Journal of applied physiology.

[11]  I. Khan,et al.  HIV-Related pulmonary hypertension: analytic review of 131 cases. , 2000, Chest.

[12]  S. Schneeweiss,et al.  Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. , 2000, Chest.

[13]  R. Rothman,et al.  Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. , 1999, Circulation.

[14]  S. Salvi.  α1-Adrenergic Hypothesis for Pulmonary Hypertension , 1999 .

[15]  J Benichou,et al.  Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. , 1996, The New England journal of medicine.

[16]  J. Collazos,et al.  Acute, reversible pulmonary hypertension associated with cocaine use. , 1996, Respiratory medicine.

[17]  M. Eisenberg,et al.  Pulmonary artery hypertension in chronic intravenous cocaine users. , 1995, American heart journal.

[18]  G. Simonneau,et al.  Primary pulmonary hypertension and fenfluramine use. , 1993, British heart journal.

[19]  T. Petty,et al.  Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine. , 1993, Chest.

[20]  W. Förster,et al.  [Clinical-pharmacological studies on the effect of mephentermin and methamphetamine on the hemodynamics of the lung circulation]. , 1975, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.

[21]  J. Padbury,et al.  Expression of a pulmonary endothelial norepinephrine transporter , 1998, Journal of Neural Transmission.

[22]  D. Tashkin,et al.  Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers. , 1997, Chest.